Sentinel Lymph Node Mapping Before Node Biopsy or Removal

Sentinel-node mapping aims to identify the first draining node, which may not be the nearest or largest node, before sampling or surgery.

Mapping techniques use selected tracers and imaging or intraoperative detection to follow lymphatic drainage from the tumor region. Availability, method, anesthesia, timing, and experience vary between centers.

Finding and testing the biologically relevant node may improve regional staging for selected solid tumors and can change node removal, radiation fields, systemic treatment discussion, and prognosis counseling.

A well-defined procedural goal may be diagnosis, local control, restoration of function, prevention of a predictable complication, or comfort. The likely benefit must be weighed against anesthesia, hospitalization, recovery, anatomy, stage, comorbidities, and the family’s goals.

Discuss before the first incision whenever procedure choice, biopsy tract, margins, reconstruction, specialist equipment, staging, pathology handling, or postoperative support could affect later options. Build pain, nutrition, mobility, wound, and emergency plans before discharge.

Veterinary studies and reviews support feasibility for selected tumors while showing technique differences, occasional mapping failure, and an evolving evidence base. Mapping identifies a target; cytology or histopathology is still required to determine metastatic status.

Tracer reaction, injection discomfort, radiation exposure with some methods, anesthesia, surgical complications, failure to identify a node, or removal of a node that proves nonmetastatic are possible. Results cannot be generalized across all tumors.

Do not change fasting, prescription medicines, anticoagulants, steroids, NSAIDs, supplements, wound care, activity, or feeding instructions without the procedural team. New bleeding, breathing difficulty, collapse, severe pain, repeated vomiting, wound opening, or loss of function needs prompt assessment.